Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 20, 2017 ) Browse 75 market data Tables and 68 Figures spread through 113 Pages and in-depth TOC on "Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020" <||>rnhttp://www.marketsandmarkets.com/Market-Reports/radioimmunoassay-market-172815697.html Early buyers will receive 10% customization on reports.
The technique of radioimmunoassay is basically used to measure the concentration of specific antigens by using specific antibodies. This technique is mainly used for research purposes rather than diagnostics purposes. This market constituted 2.3% share of the global immunoassay market.
Request Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=172815697
Radioimmunoassay has applications in the field of clinical diagnostics, and is used in hospitals, contract research organizations (CRO), laboratories, pharmaceutical companies, and others. It is used for the early detection and diagnosis of cancer, recognition of endocrinological disorders, and various other applications. Pharmaceuticals companies use the RIA techniques for medicine and drug testing. Radioimmunoassay also has its application in the research purposes, and this segment contributed a share of 65.9% to the overall market in 2014.
Over the years, there has been a significant growth in the utilization of radioimmunoassay technique in Europe owing to the advancements in medical research, clinical trials, and pharmaceutical industries. Over the next five years, the growth in the Asian radioimmunoassay market is expected to be centered in China, India, and Japan. The European radioimmunoassay market contributed the largest share in the global market, and was valued at $121.5 million in 2014. It is projected to reach $154.6 million by 2020, at a CAGR of 3.9% during the given forecast period. The limitations of the global RIA market are its high cost; government restrictions; and continuous innovations in the biomedical research for other immunoassay techniques, such as enzyme-linked immunosorbent assay (ELISA) kits. Major companies operational in the radioimmunoassay market are DIAsource ImmunoAssays SA (Europe), Immunotec Inc. (Canada), and DIAsource ImmunoAssay S.A.(Europe).
Speak To Our Analyst@ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=172815697
Some of the major players in the global radioimmunoassay market are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany).
The research study is aimed at identifying emerging trends and opportunities in the global radioimmunoassay market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global radioimmunoassay (RIA) market on the basis of type, application, end user, and geography.
Apart from the market segmentation, this report also makes use of the Porter’s Five Forces Analysis, which provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global radioimmunoassay market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|